FMP

FMP

Enter

CNSP - CNS Pharmaceuticals, Inc.

Profile of CNS Pharmaceuticals, Inc.(CNSP), CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-can

photo-url-https://financialmodelingprep.com/image-stock/CNSP.png

CNS Pharmaceuticals, Inc.

CNSP

NASDAQ

0.362 USD

-0.0068 (-1.88%)

About

ceo

Mr. John Michael Climaco Esq., J.D.

sector

Healthcare

industry

Biotechnology

website

https://www.cnspharma.com

exchange

NASDAQ

Description

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.

CIK

0001729427

ISIN

US18978H2013

CUSIP

18978H102

Address

2100 West Loop South

Phone

800 946 9185

Country

US

Employee

3

IPO Date

Nov 8, 2019

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep